Advertisement
Screener

Electromed, Inc. (ELMD) Overview

Electromed, Inc. (ELMD) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.35; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual 0.32; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.25; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual 0.21; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$21.99$25.77$30.21$35.40$41.49$48.632025-11-062026-11-06$8.31$11.83$16.85$23.99$34.15$48.632021-11-082026-11-06$3.26$5.59$9.61$16.49$28.32$48.632016-11-072026-11-06$0.87$1.95$4.36$9.74$21.77$48.632010-08-132026-11-06$0.87$1.95$4.36$9.74$21.77$48.632010-08-132026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$26.96
Previous close
$28.33
Change
-$1.37
Change (%)
-4.84%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ELMD
-2.71%
S&P 500
(m)

1 year

ELMD
+15.44%
S&P 500
(m)

3 years

ELMD
+172.67%
S&P 500
(m)

5 years

ELMD
+154.77%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual 0.35

0.130.230.330.430.5331 Dec 2024: estimate (m); actual 0.2231 Dec 2024(m)31 Mar 2025: estimate (m); actual 0.2131 Mar 2025(m)30 Sept 2025: estimate (m); actual 0.2530 Sept 2025(m)31 Dec 2025: estimate (m); actual 0.3231 Dec 2025(m)31 Mar 2026: estimate (m); actual 0.3531 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)0.35(m)(m)
1 Oct 202531 Dec 2025(m)0.32(m)(m)
1 Jul 202530 Sept 2025(m)0.25(m)(m)
1 Jan 202531 Mar 2025(m)0.21(m)(m)
1 Oct 202431 Dec 2024(m)0.22(m)(m)

30 Jun 2026 ○ Estimate (m) ● Actual 1.30

0.180.510.831.161.4830 Jun 2022: estimate (m); actual 0.2630 Jun 2022(m)30 Jun 2023: estimate (m); actual 0.3630 Jun 2023(m)30 Jun 2024: estimate (m); actual 0.5830 Jun 2024(m)30 Jun 2025: estimate (m); actual 0.8530 Jun 2025(m)30 Jun 2026: estimate (m); actual 1.3030 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jul 202530 Jun 2026(m)1.30(m)(m)
1 Jul 202430 Jun 2025(m)0.85(m)(m)
1 Jul 202330 Jun 2024(m)0.58(m)(m)
1 Jul 202230 Jun 2023(m)0.36(m)(m)
1 Jul 202130 Jun 2022(m)0.26(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 19.42M* ■ Earnings 3.40M* — Profit margin 17.52%*

-2.33M11.6%5.70M13.9%13.72M16.2%21.75M18.5%30 Sept 2025: revenue 16.89M; earnings 2.14M; profit margin 12.65%30 Sept 202531 Dec 2025: revenue 18.90M; earnings 2.76M; profit margin 14.61%31 Dec 202531 Mar 2026: revenue 18.57M; earnings 3.00M; profit margin 16.17%31 Mar 202630 Jun 2026: revenue 19.42M*; earnings 3.40M*; profit margin 17.52%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2026-04-01 to 2026-06-30; USD.30 Jun 2026

30 Jun 2026 ■ Revenue 73.78M ■ Earnings 11.30M — Profit margin 15.32%

-8.85M5.6%21.64M9.2%52.14M12.7%82.63M16.3%30 Jun 2023: revenue 48.07M; earnings 3.17M; profit margin 6.59%30 Jun 202330 Jun 2024: revenue 54.72M; earnings 5.15M; profit margin 9.41%30 Jun 202430 Jun 2025: revenue 64.00M; earnings 7.54M; profit margin 11.78%30 Jun 202530 Jun 2026: revenue 73.78M; earnings 11.30M; profit margin 15.32%30 Jun 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$26.96(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$26.96High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning ELMD

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$11.30M
Profit margin
15.32%
Return on assets · 12 month
18.82%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
197.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
101.12K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
2.76%*
Total return · month
-4.29%*
Total return · quarter
-32.91%*
Total return · half year
15.40%*
Total return · year to date
-2.71%*
Total return · 1 year
15.44%*
Total return · 3 years
172.67%*
Total return · 5 years
154.77%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$73.78M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Electromed, Inc. Overview

View more →

(m)

(m)

SEC CIK
1488917
Industry (SIC)
3845 Electromedical & Electrotherapeutic Apparatus
Country of operation
United States
Business address
500 SIXTH AVENUE NW, NEW PRAGUE, Minnesota, 56071, United States
Fiscal year end
0630
Phone
952-758-9299

Similar stocks

Stock NameCountryMarket CapPE Ratio
EDAP TMS SA (FOCL)$0.171B
CapsoVision, Inc (CV)United States$0.310B-12.68
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B